Homologous recombination repair gene mutations predict the efficacy of immune checkpoint inhibitors therapy in colorectal cancer

被引：0
|
作者：
Lin, Y. [1 ]
Zhang, J. [1 ]
Liao, X. [1 ]
Zhang, Y. [1 ]
Luo, M. [1 ]
Li, Q. [1 ]
Xie, M. [1 ]
Liang, C. [1 ]
Liao, S. [1 ]
Zheng, Y. [2 ]
Hu, X. [2 ]
Huang, M. [2 ]
Liang, R. [1 ]
Li, Y. [1 ]
机构：
[1] Guangxi Med Univ, Canc Hosp, Digest Oncol, Nanning, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.970
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
449P
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors in Cancer Therapy
    Shiravand, Yavar
    Khodadadi, Faezeh
    Kashani, Seyyed Mohammad Amin
    Hosseini-Fard, Seyed Reza
    Hosseini, Shadi
    Sadeghirad, Habib
    Ladwa, Rahul
    O'Byrne, Ken
    Kulasinghe, Arutha
    CURRENT ONCOLOGY, 2022, 29 (05) : 3044 - 3060
  • [32] Clinical implications of homologous recombination repair mutations in prostate cancer
    Cresta Morgado, Pablo
    Mateo, Joaquin
    PROSTATE, 2022, 82 : S45 - S59
  • [33] A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies
    Shao, Changxia
    Wan, Jun
    Lam, Fred C.
    Tang, Huilin
    Marley, Andrew R.
    Song, Yiqing
    Miller, Chelsey
    Brown, Madeline
    Han, Jiali
    Adeboyeje, Gboyega
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2022, 63 (06) : 308 - 316
  • [34] Homologous recombination repair gene mutations in Chinese localized and locally advanced prostate cancer patients
    Jiang, Xingran
    Hu, Xiumei
    Gu, Yajuan
    Li, Yunlong
    Jin, Mulan
    Zhao, Hongying
    Gao, Ruixia
    Huang, Zhan
    Lu, Jun
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 224
  • [35] Effect of KDR mutations on efficacy of immune checkpoint inhibitors in patients with bladder cancer.
    Dai, Honghai
    Zhang, Qin
    Tan, Yuan
    Duan, Qianqian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes
    Trigos, Anna Sofia
    Pasam, Anupama
    Banks, Patricia
    Wallace, Roslyn
    Guo, Christina
    Keam, Simon
    Thorne, Heather
    Mitchell, Catherine
    Lade, Stephen
    Clouston, David
    Hakansson, Alexander
    Liu, Yang
    Blyth, Benjamin
    Murphy, Declan
    Lawrentschuk, Nathan
    Bolton, Damien
    Moon, Daniel
    Darcy, Phil
    Haupt, Ygal
    Williams, Scott G.
    Castro, Elena
    Olmos, David
    Goode, David
    Neeson, Paul
    Sandhu, Shahneen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [37] Results and challenges of immune checkpoint inhibitors in colorectal cancer
    Emambux, Sheik
    Tachon, Gaelle
    Junca, Audelaure
    Tougeron, David
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (05) : 561 - 573
  • [38] Immune Checkpoint Inhibitors in pMMR/MSS Colorectal Cancer
    El Hajj, Joanna
    Reddy, Sarah
    Verma, Nilesh
    Huang, Emina H.
    Kazmi, Syed M.
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (04) : 1017 - 1030
  • [39] Immune checkpoint inhibitors in colorectal cancer: limitation and challenges
    Yan, Suying
    Wang, Wanting
    Feng, Zhiqiang
    Xue, Jun
    Liang, Weizheng
    Wu, Xueliang
    Tan, Zhiquan
    Zhang, Xipeng
    Zhang, Shuai
    Li, Xichuan
    Zhang, Chunze
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] Immune Checkpoint Inhibitors in pMMR/MSS Colorectal Cancer
    Joanna El Hajj
    Sarah Reddy
    Nilesh Verma
    Emina H. Huang
    Syed M. Kazmi
    Journal of Gastrointestinal Cancer, 2023, 54 : 1017 - 1030
12345